Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Non-Squamous Non-Small Cell Lung Cancer × Pemetrexed × Clear all

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Adenocarcinoma of Lung 3 Meningeal Carcinomatosis 2 Lung Neoplasms 2 Non-squamous Non-small Cell Lung Cancer 1 Non-squamous Cell Non-Small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06334757 2024-03-28

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Henan Cancer Hospital

Phase 2 Unknown

Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡